xB3-IL-1RA

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamexB3-IL-1RA
Drug Alias NameIL-1 receptor antagonist (bioasis Technologies)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsAllergic encephalitisNeuralgiaMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioasis Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioasis Technologies Inc
Active IndicationsN/A
Inactive IndicationsAllergic encephalitisNeuralgiaMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A